Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Zentynel Frontier Investments is the first venture capital fund specialized in biotechnology in Latin America. Founded through the collaborative vision of Fundación Ciencia & Vida and Venturance Alternative Assets, the organization combines capital, scientific knowledge, and operational experience to assist entrepreneurs in transforming innovative science into scalable businesses. Zentynel has invested in 17 companies across six countries, catalyzing over $100 million in co-investments, and aims to bridge the significant capital gap in the region.
Zentynel invests in early-stage ventures with global ambitions that have strong ties to Latin America. Their investment areas include human and animal health, digital health, AI-driven platforms, agrotechnology, food technology, and environmental biotechnology. Typical investments range from $1 million to $2 million, with a portion reserved for follow-on investments.
Zentynel's portfolio includes notable companies such as HeXemBio, pioneers in cellular rejuvenation; Asclepii, focused on regenerative medicine for wound care; Fecundis, providing affordable fertility treatments; and ViewMind, utilizing AI to monitor neurocognitive conditions. Other companies include Axenya, Xeptiva, Biomakers, and Autem Medical, addressing various health and sustainability challenges.
To approach Zentynel Frontier Investments, founders should submit their pitch through the official website at zentynel.com. The firm is particularly interested in early-stage ventures with strong ties to Latin America and global ambitions.
Zentynel Frontier Investments is actively deploying its capital, with the most recent investment in Asclepii, a company focused on medical supplies, made in March 2025. The firm has also participated in significant funding rounds, including a $10 million Series A-1 for Autem Therapeutics in June 2022.
Zentynel invests in Pre Seed, Seed, Seed Plus, and Series A stages.
Founders can pitch Zentynel through their website at zentynel.com.
Zentynel focuses on biotech, healthcare, agtech, digital health, and AI sectors.
Zentynel typically invests between $1 million and $2 million.
Zentynel invests primarily in Latin America, North America, and Europe.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.